findmyKOL
Clinical trialNCT07392190RecruitingPhase 3Interventional

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

SponsorEli Lilly and CompanyEnrollment900ObesityOverweight
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo in participants with persistent obesity or overweight, with or without type 2 diabetes, and on stable incretin background therapy. Participation in the study will last about 80 weeks.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Eli Lilly and Company

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

187 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Emeritus Research

    Botany, Australia

    Paul Bird
    Recruiting
  • Box Hill Hospital

    Box Hill, Australia

    Ming Li Yee
    Recruiting
  • Royal Brisbane and Women'S Hospital

    Brisbane, Australia

    Donald McLeod
    Recruiting
  • Emeritus Research

    Camberwell, Australia

    Sam Francis
    Recruiting
  • Barwon Health

    Geelong, Australia

    Kay Hau (Aaron) Choy
    Recruiting
  • Austin Health - Repatriation Hospital

    Heidelberg West, Australia

    Elif Ekinci
    Recruiting
  • Aim Research

    Merewether, Australia

    Claire Morbey
    Recruiting
  • Southern Adelaide Diabetes & Endocrine Services

    Oaklands Park, Australia

    Jui Ho
    Recruiting
  • Royal North Shore Hospital

    St Leonards, Australia

    Sarah Glastras
    Recruiting
  • Innovate Clinical Research

    Waitara, Australia

    Rachel Graham
    Recruiting
Belgium
  • Imelda General Hospital

    Bonheiden, Belgium

    Chris Vercammen
    Recruiting
  • Université Libre de Bruxelles - Hôpital Erasme

    Brussels, Belgium

    Laurent Crenier
    Recruiting
  • Ziekenhuis Oost-Limburg, Campus St.-Jan

    Genk, Belgium

    David Verhaert
    Recruiting
  • Jan Yperman Ziekenhuis

    Ieper, Belgium

    An Nollet
    Recruiting
  • Az Groeninge Campus Kennedylaan

    Kortrijk, Belgium

    Gerd Vanhaverbeke
    Recruiting
  • Uz Leuven

    Leuven, Belgium

    Roman Vangoitsenhoven
    Recruiting
  • Az Sint-Maarten

    Mechelen, Belgium

    Michel Vandenbroucke
    Recruiting
  • Meclinas

    Mechelen, Belgium

    Julie Casaer
    Recruiting
  • Az Damiaan Vzw

    Ostend, Belgium

    Marianne Kerrebrouck
    Recruiting
Brazil
  • Centro de Diabetes Curitiba

    Curitiba, Brazil

    LUCIANA PECHMANN
    Not, yet, recruiting
  • Quanta Diagnóstico E Terapia

    Curitiba, Brazil

    Rosangela Rea
    Not, yet, recruiting
  • Private Practice - Dr.Miguel N. Hissa

    Fortaleza, Brazil

    Miguel Hissa
    Not, yet, recruiting
  • Cpclin

    São Paulo, Brazil

    Denise Franco
    Not, yet, recruiting
  • Hospital 9 de Julho

    São Paulo, Brazil

    Layana Sandes Fraga
    Not, yet, recruiting
  • Cedoes

    Vitória, Brazil

    Queulla Santos
    Not, yet, recruiting
  • Integral Pesquisa E Ensino

    Votuporanga, Brazil

    GRACIELLY PANTANO
    Not, yet, recruiting
China
  • the First Hospital of Jilin University

    Changchun, China

    Guixia Wang
    Not, yet, recruiting
  • the Second Hospital of Jilin University

    Changchun, China

    Hanqing Cai
    Not, yet, recruiting
  • the Second Xiangya Hospital of Central South University

    Changsha, China

    Xia Li
    Not, yet, recruiting
  • Sichuan Provincial People'S Hospital

    Chengdu, China

    Limin Tian
    Not, yet, recruiting
  • West China Hospital Sichuan University

    Chengdu, China

    zhenmei an
    Not, yet, recruiting
  • 2nd Affiliated Hospital Chongqing Medical Universi

    Chongqing, China

    Dongfang Liu
    Not, yet, recruiting
  • Zhujiang Hospital

    Guangzhou, China

    Jia Sun
    Not, yet, recruiting
  • the Affiliated Hospital of Guizhou Medical University

    Guiyang, China

    Miao Zhang
    Not, yet, recruiting
  • the Second People'S Hospital of Hefei

    Hefei, China

    Jun Ye
    Not, yet, recruiting
  • Huzhou Central Hospital

    Huzhou, China

    Shunbin Li
    Not, yet, recruiting
  • Jinan Central Hospital

    Jinan, China

    Nianrong Mi
    Not, yet, recruiting
  • the First Affiliated Hospital of Henan University of Science &technology

    Luoyang Shi, China

    Hongwei Jiang
    Not, yet, recruiting
  • Affiliated Hospital of Luzhou Medical College

    Luzhou, China

    Qin Wan
    Not, yet, recruiting
  • Jiangxi Provincial People'S Hospital

    Nanchang, China

    Zongyou Cheng
    Not, yet, recruiting
147 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

EloralintidePlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Feb 2026
Primary completion
30 Jun 2028
Completion
31 Jul 2028
Last update posted
21 Aug 2026
Registered enrollment
900
Registry id
NCT07392190

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-523659-73-00

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.